Dr. Manoop S. Bhutani, MD

Dr. Bhutani practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Bhutani's NPI, 1003989310, was assigned on November 16, 2006. Dr. Bhutani graduated from Pt. B.D. Sharma Postgrad Institute of Medical Science in 1988. Dr. Bhutani's Texas license number on file is L4867.

Dr. Bhutani's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Bhutani's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bhutani practices. Vendor and product names are available with a free account.

Gastroenterology is Dr. Bhutani's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Bhutani is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Bhutani's licenses on file in 5 states: Texas, Florida, Ohio, South Carolina and Iowa.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic indigestion, colonoscopy and upper GI endoscopy among the conditions Dr. Bhutani treats.

CMS data shows 342 Medicare services from Dr. Bhutani across 8 procedure codes in 2024, for 238 Medicare patients. Medicare paid $28,154 for them.

CMS counts 238 Medicare patients who saw Dr. Bhutani in 2024. The largest group is 65 to 74, with 138 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 2.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bhutani's median patient age at 70, with 57% women.

In 2024, Dr. Bhutani wrote 75 Medicare Part D claims for 40 patients. 97% of them were for generic drugs. CMS names the drug for 45 of them, across 3 drugs with 11 or more claims each, at $234 in total drug cost. In 2023, CMS named 43 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Bhutani for performance year 2024, reported as part of a group. Dr. Bhutani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bhutani as offering telehealth. CMS counts 205 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Bhutani, more than 90% of the clinicians it reports for that procedure.

Dmand AI links 437 papers to Dr. Bhutani, published from 2004 to 2025. 2020 was the busiest year, with 29. The most frequent topics are Endosonography, Adenocarcinoma and Pancreatic Neoplasms. Dr. Bhutani has published most often in Endosc Ultrasound. Dr. Bhutani's most frequent co-authors are Jaffer A. Ajani, MD, Jeffrey Lee, MD and Brian Roy Weston, MD.

Dmand AI links Dr. Bhutani to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Pancreatic Cyst and Cysts.

CMS Open Payments shows 31 general payments to Dr. Bhutani from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Boston Scientific Corporation paid the most, $932.

Dr. Bhutani graduated from Pt. B.D. Sharma Postgrad Institute of Medical Science in 1988.

Dr. Bhutani is in network with 7 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 5. Check the plan with the practice before a visit.